E-ISSN 2602-3164

Clinicopathological Characteristics of Patients with HR-Positive/HER2-Negative Metastatic Breast Cancer Experiencing Early Progression Within 6 Months of CDK4/6 Inhibitor Therapy

EJMI & EJMI